Skip to the answer

Pantoprazole Uses, Dosage, Side Effects and Interactions

Brand names
Protonix

Protonix was the first pantoprazole product the FDA approved, in February 2000. An FDA-approved generic with the same active ingredient is listed.

Protonix I.V.

Protonix I.V. is a brand name for pantoprazole. Generic pantoprazole is listed with the FDA.

Protonix Delayed-Release

Protonix Delayed-Release is a brand name for pantoprazole. Generic pantoprazole is listed with the FDA.

Pantoprazole is a proton pump inhibitor (a stomach acid reducer) used to treat and maintain healing of erosive esophagitis from gastroesophageal reflux disease (GERD), and to treat conditions of excess stomach acid such as Zollinger-Ellison syndrome.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About PantoprazoleType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Pantoprazole in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Pantoprazole (Protonix) is a proton pump inhibitor that blocks the last step of stomach acid production, a common first choice for healing and then protecting erosive esophagitis (damage to the esophagus lining) from GERD and for excess-acid conditions such as Zollinger-Ellison syndrome; it has been on the U.S. market since about 2000, with FDA-approved generics listed. Most people tolerate it well, and headache or diarrhea are the side effects most often noticed. Watch for diarrhea that does not improve, which can be a gut infection called C. difficile, and stop it and get help right away for a blistering or peeling rash.

Key Takeaways From the HelloPharmacist Team

  • Take it once daily (twice for Zollinger-Ellison); tablets are fine with or without food, but granules go about 30 minutes before a meal.
  • Healing courses run up to 8 weeks; if you stay on it longer, ask about magnesium and vitamin B-12 checks and bone health.
  • If you take warfarin, expect extra INR (clotting) checks, and know it can lower how well iron and some antifungals are absorbed.
  • Report feeling generally unwell with nausea and loss of appetite promptly, since that can signal kidney inflammation from this medicine.

How we write and review this content: our editorial policy

Pantoprazole by the Numbers

Strengths
8
across 3 forms
Makers and packagers
68
Earliest FDA record
2000
Rank by Medicaid prescriptions
#32 of 1,682 drugs
More prescriptions than 98% of the 1,682 drugs we measure
5.79 million prescriptions, Q1–Q4 2025
Other forms and routes

Patient Information Guide for Pantoprazole

What It’s Used For

Pantoprazole is a proton pump inhibitor used for acid-related conditions. Uses depend on the product:

  • Oral tablets and oral suspension granules (including Protonix): short-term treatment (up to 8 weeks) of erosive esophagitis associated with GERD in adults and children 5 years and older.
  • Oral forms (adults): maintenance of healing of erosive esophagitis and reduction in relapse of daytime and nighttime heartburn in GERD.
  • Oral forms: long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
  • Pantoprazole sodium for injection (intravenous): GERD with a history of erosive esophagitis for up to 10 days in adults, and pathological hypersecretory conditions including Zollinger-Ellison syndrome in adults. One injection product is labeled for 7 to 10 days.
  • Protonix I.V.: also labeled for children 3 months and older for up to 7 days.
  • Injection products are not established for upper gastrointestinal bleeding.

How It Works

Pantoprazole blocks the final step of stomach acid production. It binds to the (H+, K+)-ATPase “proton pump” enzyme in the stomach’s acid-producing cells. This lowers both baseline and stimulated acid, with an effect lasting longer than 24 hours.

Drug Class

Drug Class

  • Proton Pump Inhibitor
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Proton Pump Inhibitor

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)
  • Proton Pump Inhibitors

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Pantoprazole in the FDA’s index.

From our Patient Information GuidePantoprazole blocks the final step of stomach acid production. It binds to the (H+, K+)-ATPase “proton pump” enzyme in the stomach’s acid-producing cells. Read How Pantoprazole Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)

None listed for Pantoprazole in the FDA’s index.

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Proton pump inhibitors

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Pantoprazole is taken by mouth or given into a vein, and the plan depends on your condition and product. Your prescriber sets the dose and length of treatment.

  • Oral tablets are taken once daily for erosive esophagitis and can be taken with or without food. Zollinger-Ellison syndrome is usually dosed more often.
  • Oral suspension granules are taken about 30 minutes before a meal, for example sprinkled on applesauce or mixed with apple juice.
  • Injection is given by a healthcare professional over a few minutes or as a 15-minute infusion, and is switched to an oral medicine as soon as possible.

Follow your prescriber and the product label for dosing and what to do about missed doses.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Pantoprazole Taken by Mouth

Healing of erosive esophagitis from acid reflux (GERD)
Adults Usual dose 40 mg once daily
  • 40 mg once daily for up to 8 weeks

Good to know

For adult patients who have not healed after 8 weeks of treatment, an additional 8-week course may be considered

Children 5 years and older weighing 15 kg to less than 40 kg Usual dose 20 mg once daily
  • 20 mg once daily for up to 8 weeks
Children 5 years and older weighing 40 kg or more Usual dose 40 mg once daily
  • 40 mg once daily for up to 8 weeks
Keeping erosive esophagitis healed
For adults
Usual dose 40 mg once daily

Good to know

Controlled studies did not extend beyond 12 months

Conditions with too much stomach acid, including Zollinger-Ellison syndrome
For adults
Usual dose 40 mg twice a day

Highest dose studied Doses up to 240 mg daily have been administered

Good to know

Adjust to individual patient needs and continue as long as clinically indicated

See the Full Dosing Instructions on DailyMed →

Pantoprazole Injection

Acid reflux (GERD) with a history of erosive esophagitis
For adults
Usual dose 40 mg once daily
  • 40 mg once daily by intravenous injection (over at least 2 minutes) or intravenous infusion (for 15 minutes) for up to 10 days

Good to know

Switch to an appropriate oral medication within 10 days

GERD stands for gastroesophageal reflux disease.

Conditions with too much stomach acid, including Zollinger-Ellison syndrome
For adults
Usual dose 80 mg every 12 hours
  • 80 mg every 12 hours by intravenous injection (over at least 2 minutes) or intravenous infusion (for 15 minutes)

Good to know

Dosing frequency adjusted to acid output; for higher needs, 80 mg intravenously every 8 hours

See the Full Dosing Instructions on DailyMed →

Side Effects

Common side effects in adults include:

Common side effects

  • Headache
  • Diarrhea
  • Nausea
  • Abdominal (belly) pain
  • Vomiting
  • Gas (flatulence)
  • Dizziness
  • Joint pain

When to get medical help

  • Severe skin reactions such as blistering, peeling or widespread rash, or signs of a serious allergic reaction like swelling or trouble breathing: stop the medicine and get medical help right away.
  • Signs of kidney inflammation (acute tubulointerstitial nephritis), such as feeling unwell, nausea, loss of appetite or reduced kidney function: tell your doctor promptly.
  • Diarrhea that does not improve: it could be a Clostridium difficile infection.
  • A new or worsening rash, especially on sun-exposed skin, or joint pain: this could be lupus, so contact your doctor.
  • Muscle spasms, irregular heartbeat or seizures: these can be signs of low magnesium.
  • Symptoms that return soon after treatment or respond poorly: tell your doctor so other causes, including stomach cancer, can be checked.

In children, upper respiratory infection, fever and rash were also common. Seek help for severe skin reactions, allergic reactions, diarrhea that does not improve, signs of kidney problems, new rash or joint pain, or muscle spasms and irregular heartbeat.

Warnings and Precautions

  • Stomach cancer is not ruled out by symptom relief in adults. Poor response or early return of symptoms may call for more testing.
  • Kidney inflammation (acute tubulointerstitial nephritis) can occur at any point during treatment.
  • C. difficile diarrhea risk may be higher with PPIs, especially in hospitalized patients.
  • Bone fractures of the hip, wrist or spine are linked with high-dose or year-plus use.
  • Severe skin reactions and lupus have been reported. The medicine should be stopped if they occur.
  • Low vitamin B-12 or magnesium can occur with long-term use.
  • Fundic gland polyps risk rises with use beyond one year.
  • In long-term rodent studies, pantoprazole caused tumors. The relevance to humans is unknown.

Interactions

Pantoprazole can affect, or be affected by, several medicines:

  • Rilpivirine products: must not be combined.
  • Nelfinavir, atazanavir, saquinavir: may lower or raise levels of these HIV drugs.
  • Warfarin: can raise INR and bleeding risk.
  • High-dose methotrexate: levels may rise and last longer.
  • Drugs needing stomach acid (iron salts, erlotinib, dasatinib, nilotinib, ketoconazole, itraconazole): absorption can drop.
  • Mycophenolate mofetil: exposure to its active form may drop.
  • Clopidogrel: no dose adjustment needed.
  • Lab tests: can cause false-positive urine THC and neuroendocrine tumor tests.

Interactions Listed in the FDA-Approved Label

From the Pantoprazole prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Rilpivirine-containing products
    What happensDecreased exposure may reduce antiviral effect and promote drug resistance.
    What to doConcomitant use is contraindicated.
  • What happensDecreased exposure may reduce antiviral effect and promote drug resistance.
    What to doSee prescribing information for atazanavir for dosing information.
  • What happensDecreased exposure may reduce antiviral effect and promote drug resistance.
    What to doAvoid concomitant use.
  • Saquinavir
    What happensIncreased exposure may increase toxicity of saquinavir.
    What to doMonitor for potential saquinavir toxicities.
  • What happensIncreased INR and prothrombin time, which may lead to abnormal bleeding and even death.
    What to doMonitor INR and prothrombin time; warfarin dose adjustment may be needed.
  • What happensNo clinically important effect on exposure to clopidogrel's active metabolite or platelet inhibition.
    What to doNo dose adjustment of clopidogrel is necessary.
  • What happensMay elevate and prolong serum levels of methotrexate and/or hydroxymethotrexate, possibly leading to toxicity.
    What to doA temporary withdrawal of pantoprazole may be considered in some patients on high-dose methotrexate.
  • Mycophenolate mofetil
    What happensReduces exposure to the active metabolite mycophenolic acid; clinical relevance on organ rejection not established.
    What to doUse with caution in transplant patients receiving MMF.
  • Drugs dependent on gastric pH for absorption For example: iron salts, erlotinib, dasatinib, nilotinib, ketoconazole/itraconazole
    What happensPantoprazole can reduce their absorption by reducing intragastric acidity.
    What to doSee the prescribing information for those drugs.
  • Neuroendocrine tumor investigations (CgA tests)
    What happensCgA levels increase, which may cause false positive results.
    What to doTemporarily stop pantoprazole at least 14 days before assessing CgA levels; use the same laboratory for serial tests.
Read the label’s full interactions text

7 DRUG INTERACTIONS Table 4 includes drugs with clinically important drug interactions and interaction with diagnostics when administered concomitantly with pantoprazole sodium for delayed-release oral suspension and instructions for preventing or managing them. Consult the labeling of concomitantly used drugs to obtain further information about interactions with PPIs. Table 4: Clinically Relevant Interactions Affecting Drugs Co-Administered with Pantoprazole Sodium for Delayed-Release Oral Suspension and Interactions with Diagnostics Antiretrovirals Clinical Impact: The effect of PPIs on antiretroviral drugs is variable. The clinical importance and the mechanisms behind these interactions are not always known. Decreased exposure of some antiretroviral drugs (e.g., rilpivirine, atazanavir, and nelfinavir) when used concomitantly with pantoprazole may reduce antiviral effect and promote the development of drug resistance. Increased exposure of other antiretroviral drugs (e.g., saquinavir) when used concomitantly with pantoprazole may increase toxicity of the antiretroviral drugs. There are other antiretroviral drugs which do not result in clinically relevant interactions with pantoprazole. Intervention: Rilpivirine-containing products: Concomitant use with pantoprazole sodium for delayed-release oral suspension is contraindicated. See prescribing information. Atazanavir: See prescribing information for atazanavir for dosing information. Nelfinavir: Avoid concomitant use with pantoprazole sodium for delayed-release oral suspension. See prescribing information for nelfinavir. Saquinavir: See the prescribing information for saquinavir and monitor for potential saquinavir toxicities. Other antiretrovirals: See prescribing information. Warfarin Clinical Impact: Increased INR and prothrombin time in patients receiving PPIs, including pantoprazole, and warfarin concomitantly.

Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Do not use if allergic to pantoprazole or similar medicines (substituted benzimidazoles), or if taking rilpivirine.
  • Tell your prescriber if you are pregnant, planning pregnancy or breastfeeding.
  • Oral use for erosive esophagitis is labeled for children 5 years and older. Safety beyond 8 weeks in children is not established.
  • Older adults with a poor response may need further evaluation.
  • Mention low magnesium or calcium, osteoporosis risk, lupus, or use of digoxin or diuretics.

Overdose

Experience with very high doses (above 240 mg) is limited, and reports have generally fit the known safety profile. Pantoprazole is not removed by hemodialysis, so treatment is symptomatic and supportive. If you think too much was taken, call Poison Control at 1-800-222-1222.

Half-Life and How Your Body Processes It

Delayed-release tablets are enteric-coated, so absorption begins only after they leave the stomach, with peak levels in about 2.5 hours. Food may delay absorption but does not change the amount absorbed from tablets. Pantoprazole is broken down in the liver (mainly CYP2C19 and CYP3A4) and has a half-life of about one hour. Most of it leaves in the urine as metabolites, with the rest in the feces.

Storage

Store PROTONIX For Delayed-Release Oral Suspension and PROTONIX Delayed-Release Tablets at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) .

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Supplements and Herbs That Interact With Pantoprazole

From the licensed clinical database we use, rolled up per supplement, most serious first.

157 supplements and herbal products have documented interactions with Pantoprazole in the licensed clinical database we use.

Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.

  • 3Major
  • 103Moderate
  • 51Minor

See the other 149

Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

Nutrients Pantoprazole May Deplete

Nutrients Pantoprazole has been linked with lower levels of, from the licensed clinical database we use.

Pantoprazole has been associated with lower levels of 9 nutrients in the clinical literature. This does not mean a deficiency will occur. It means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.

Evidence and significance: 1 higher significance, 1 moderate, 4 lower / possible, 3 unrated

See the other 1

Educational information from a licensed clinical database (Natural Medicines), not medical advice. Do not start or stop medications or supplements without professional guidance.

Pantoprazole: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Pantoprazole — the kind of thing our pharmacy team would talk through with you at the counter.

What is pantoprazole used for?

It lowers stomach acid. By mouth, it treats and helps keep healed erosive esophagitis from GERD, and treats conditions of excess acid like Zollinger-Ellison syndrome. The injection is used in hospital settings for GERD with a history of erosive esophagitis and for excess-acid conditions.

How should I take pantoprazole?

Take it as your prescriber directs, usually once daily for esophagitis. Tablets can be taken with or without food. If you use the granules, take them about 30 minutes before a meal, for example on applesauce or mixed in apple juice.

What side effects should I expect?

The most common are headache, diarrhea, nausea, belly pain, vomiting, gas, dizziness and joint pain. Call your doctor for severe skin reactions, signs of allergic reaction, diarrhea that will not go away, new rash or joint pain, or muscle spasms.

Can I take pantoprazole with other medicines?

Some medicines need attention. You must not take it with rilpivirine HIV products. Tell us if you take warfarin, methotrexate, other HIV medicines, mycophenolate, or drugs like iron, ketoconazole or itraconazole that need stomach acid to be absorbed.

Is pantoprazole safe during pregnancy or breastfeeding?

Studies in people have not shown a link to birth defects, but animal studies showed bone changes in offspring, so talk with your doctor. Small amounts pass into breast milk, and no effects were seen in the infant studied.

Is it okay to use pantoprazole for a long time?

Your doctor will aim for the lowest dose and shortest time that works. Long-term use is linked with a higher risk of bone fractures, low vitamin B-12 and magnesium, and stomach polyps. Ask your prescriber whether you need periodic checks.

Is pantoprazole available over the counter?

No. Pantoprazole is a prescription medicine: every pantoprazole product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was pantoprazole first available?

The earliest FDA record we hold for pantoprazole is from 2000: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when pantoprazole was first used.

Who makes pantoprazole?

68 companies currently list pantoprazole products in the FDA's NDC Directory, including Cardinal Health 107, LLC, NuCare Pharmaceuticals,Inc., Bryant Ranch Prepack. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of pantoprazole?

Pantoprazole is the generic name. Its brand names are Protonix, Protonix I.V. and Protonix Delayed-Release. Generic versions are listed under the name pantoprazole.

What is the generic name of Protonix?

The generic name of Protonix is pantoprazole. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is pantoprazole?

Pantoprazole belongs to the drug class Proton Pump Inhibitor, its established pharmacologic class on the FDA label.

Is there a generic version of pantoprazole?

Yes. FDA-approved generic versions of pantoprazole are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does pantoprazole come in?

Pantoprazole is listed in the FDA's National Drug Code Directory in these forms and strengths. Delayed-release tablet (by mouth): 20 mg and 40 mg. Injection (into a vein): 40 mg, 40 mg/10 mL, 40 mg/50 mL, 40 mg/100 mL and 80 mg/100 mL. Oral powder (by mouth): 40 mg. A listing does not mean every pharmacy stocks every strength.

How much does pantoprazole cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $0.04 per generic delayed-release tablet across 2 strengths, $14.20 to $14.31 per delayed-release tablet of brand-name Protonix across 2 strengths, $2.37 each for the generic injection across 2 strengths and $2.85 each for the 40 mg generic oral powder as of November 18, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Is there a pantoprazole shortage?

No. Pantoprazole is not on the FDA's drug shortage list as of Nov 22, 2026. A single pharmacy can still run short for a while without a national shortage, and your pharmacist can tell you what they are seeing.

Where can I read the pantoprazole prescribing information (package insert)?

The full FDA-approved prescribing information for pantoprazole, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.'s, revised May 18, 2026, and links to it on DailyMed.

Can you crush pantoprazole?

Some forms of pantoprazole are on our Do Not Crush list of tablets and capsules that should not be crushed or chewed: pantoprazole sodium (tablet, delayed release); Protonix (tablet, delayed release). A delayed-release or enteric-coated form has a coating that protects the medicine from stomach acid, or the stomach from the medicine. A form that is not on the list may still come with its own instructions, so check the label and ask your pharmacist before you crush, split or open any medicine. Each listed form’s reason and instructions are on our Do Not Crush list.

Is pantoprazole gluten free?

No pantoprazole label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 162 pantoprazole products from 66 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's pantoprazole by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See pantoprazole inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Pantoprazole

Skip the scrolling. Ask in your own words and get an answer from Pantoprazole’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Pantoprazole’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Pantoprazole on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Pantoprazole Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Pantoprazole Forms and Strengths (How It Comes)

Pantoprazole comes in 3 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Pantoprazole inactive ingredients by manufacturer.

Delayed-release tablet

By mouth
Brands Protonix (the first brand, 2000)
How this form is used
What it may be used for
  • Protonix delayed-release tablets are used for short-term treatment of erosive esophagitis associated with GERD.
  • Protonix delayed-release tablets are used to maintain healing of erosive esophagitis in adults.
  • Protonix delayed-release tablets are used for long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
Important instructions
  • Pantoprazole sodium delayed-release tablets are enteric-coated and may be taken without regard to timing of meals.
Available strengths 2 strengths
129 FDA-listed product records ⓘ

Injection

Into a vein
Brands Protonix (the first brand, 2000)
How this form is used
What it may be used for
  • Pantoprazole sodium for injection is used in adults for GERD with a history of erosive esophagitis for up to 10 days.
  • Pantoprazole sodium for injection is used in adults for pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
  • Protonix I.V. is also labeled for children 3 months and older with GERD and a history of erosive esophagitis for up to 7 days.
  • Pantoprazole sodium for injection has not been shown safe and effective for upper gastrointestinal bleeding.
Important instructions
  • Pantoprazole sodium for injection is given into a vein, as a short injection or a 15-minute infusion.
  • Pantoprazole sodium for injection should be stopped as soon as you can take an oral treatment.
Available strengths 5 strengths
29 FDA-listed product records ⓘ

Oral powder

By mouth
Brands Protonix (the first brand, 2000)
How this form is used
What it may be used for
  • Protonix delayed-release granules for oral suspension are used for short-term treatment of erosive esophagitis associated with GERD.
  • Protonix delayed-release granules for oral suspension are used for maintenance of healing of erosive esophagitis in adults.
  • Protonix delayed-release granules for oral suspension are used for pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
Important instructions
  • Pantoprazole sodium delayed-release granules should be taken about 30 minutes before a meal.
  • Pantoprazole sodium delayed-release granules can be taken sprinkled on a teaspoonful of applesauce or mixed with apple juice.
Available strengths 1 strength
9 FDA-listed product records ⓘ

Pantoprazole on the U.S. Market: Products, Makers and Brands

How Pantoprazole appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

68 companies list 168 Pantoprazole product records with the FDA, mostly as delayed-release tablet, injection, oral powder; the earliest marketing or approval year on record is 2000. Brand names in the directory today include Protonix, Protonix I.V. and Protonix Delayed-Release; the rest are generics.

3
Dose forms ⓘ
68
Labelers (makers, repackagers, distributors)
3
Brand names ⓘ
168
FDA-listed product records ⓘ
2000
Earliest FDA record ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (28) · Unfinished tablet, delayed release (6) · Unfinished injection, powder, for solution (2) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

Cardinal Health 107, LLC6%
NuCare Pharmaceuticals,Inc.6%
Bryant Ranch Prepack4%
A-S Medication Solutions4%
Asclemed USA, Inc.4%
NorthStar RxLLC3%
Other makers74%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Pantoprazole Is Used (Medicaid Data)

How many Pantoprazole prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

5,789,599
Medicaid prescriptions filled (Q1–Q4 2025)
$65.8M paid by Medicaid, before rebates

How commonly is Pantoprazole prescribed? Of the 1,682 medications we measure, Pantoprazole ranks #32 by Medicaid prescriptions — more than 98% of them.

Where Pantoprazole ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Pantoprazole product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 40 mg delayed release oral tablet is the most-dispensed Pantoprazole product — about 87% of these Medicaid prescriptions.

pantoprazole 40 MG Delayed Release Oral Tablet Most dispensed

5,019,462 Medicaid prescriptions (Q1–Q4 2025) 87% of Pantoprazole prescriptions shown $49.2M paid by Medicaid, before rebates ≈ $9.81 per prescription, before rebates

30 of 265 listed NDCs had Medicaid claims. RxNorm 314200

pantoprazole 20 MG Delayed Release Oral Tablet

686,680 Medicaid prescriptions (Q1–Q4 2025) 12% of Pantoprazole prescriptions shown $6.8M paid by Medicaid, before rebates ≈ $9.91 per prescription, before rebates

16 of 242 listed NDCs had Medicaid claims. RxNorm 251872

pantoprazole 40 MG Injection

65,430 Medicaid prescriptions (Q1–Q4 2025) 1% of Pantoprazole prescriptions shown $3.5M paid by Medicaid, before rebates ≈ $54 per prescription, before rebates

21 of 71 listed NDCs had Medicaid claims. RxNorm 283669

pantoprazole 40 MG Oral Granules

18,027 Medicaid prescriptions (Q1–Q4 2025) <1% of Pantoprazole prescriptions shown $6.2M paid by Medicaid, before rebates ≈ $345 per prescription, before rebates

9 of 18 listed NDCs had Medicaid claims. RxNorm 763306

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 76 of the 596 listed Pantoprazole NDCs had Medicaid claims.

Compare Pantoprazole Products

A representative set of FDA-listed product records for Pantoprazole — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 168 of 168 products — FDA National Drug Code Directory. See every product, package size and price: browse all 168 Pantoprazole NDCs →

Pantoprazole Side Effects Reported to the FDA (FAERS)

After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Pantoprazole — a signal of what to watch for, not proof the drug caused it.

The effects most often named in FDA reports that mention Pantoprazole are chronic kidney disease, fatigue, nausea; about 81% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.

336,400
Reports mentioning it
81%
Reported as serious
12
Distinct effects shown
Most reported effects
Chronic Kidney Disease
29,276
Fatigue
25,169
Nausea
23,144
Diarrhoea
21,696
Acute Kidney Injury
21,632
Dyspnoea
21,079
Pain
19,577
Headache
16,677
Vomiting
15,879
Renal Failure
14,781
Age groups
Elderly · 29,557Adult · 28,382Adolescent · 306Neonate · 280Child · 230Infant · 55

Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Pantoprazole in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.

Pantoprazole FDA Approval History

How Pantoprazole went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.

Pantoprazole was first approved by the FDA in 2000 (Brand: PROTONIX · Wyeth Pharms); the first generic version was approved in 2007. It remains available in U.S. pharmacies today.

2000
Brand approved
Brand: PROTONIX · Wyeth Pharms
2007
First generic approved
Lower-cost ANDA competition begins
2026
Available today
Active in U.S. pharmacies

Source: Drugs@FDA.

Pantoprazole Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list 6 Pantoprazole recalls since July 2021. Three of them are still ongoing or began in the last six months and are listed first. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.

Ongoing Class II Aug 6, 2026 · Baxter Healthcare Corporation
CGMP Deviations
  • Pantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL) Single-Dose Infusion Bag in 100 mL GALAXY Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60… Lots: Lot # NC194129, Exp Date: 05/07/2028. FDA record D-0812-2026 →
Ongoing Class II Mar 26, 2026 · Hetero Labs Limited (Unit V)
Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."
  • Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Unit V, Po… Lots: Batch # FD253967, Exp Date: 06/26/2027 FDA record D-0484-2026 →
Ongoing Class II Mar 14, 2023 · Hetero USA Inc
CGMP Deviations: Discoloration
  • Pantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals Inc., Piscataway, NJ, 08854, By: Hetero Labs Limited, Unit V, Polepally, Ja… Lots: Lot #: PAN22542, Exp. Date: 9/2024 FDA record D-0530-2023 →
Class II Sep 5, 2023 · Terminated · BE PHARMACEUTICALS AG
Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.
  • Pantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-122-01 Packaged as (a) 10 Single-dose vials, NDC 71839-122-10; (b) 25 Single-dose vials, NDC 71839-122-25; Rx Only, Mfd. i… Lots: Lots: (a) GSC04002A, GSC04003A, GSC04004A, GSC04006A, Exp Mar-2024; GSC05001A, GSC05006A, GSC05007A, Exp April-2024; GSC10003A, GSC10005A Exp Sep-2024;GSC06004A, GSC06005A, Exp May-2024; GSC07001A, GSC07007A, GSC07008A, GSC07009A, Exp Jun-… FDA record D-1148-2023 →
Class II Jul 25, 2022 · Terminated · SUN PHARMACEUTICAL INDUSTRIES INC
Discoloration
  • Pantoprazole Sodium for Delayed-Release Oral Suspension*40 mg* suspension in apple juice or applesauce only Each packet contains 40 mg pantoprazole equivalent to 45.1 mg of pantoprazole sodium USP (s… Lots: Lot #: MHC1317A, Exp 07/2023 FDA record D-0068-2023 →
Class II Apr 11, 2022 · Terminated · Torrent Pharma Inc
CGMP deviations: tablets cracking
  • Pantoprazole Sodium Delayed-Release Tablets, USP, 20 mg, Rx Only, 90 tablets per bottle, Manufactured by: Torrent Pharmaceuticals Ltd., Indrad-382 721, India, Manufactured for: Torrent Pharma Inc., L… Lots: Lot #s: BA34G021, BA34G022, Exp. 09/2022 FDA record D-0852-2022 →

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Pantoprazole in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
3
Strengths
7
Forms in current FDA listings
3 of 3
In current FDA listings No current FDA listing
Ingredient (IN) Pantoprazole RxCUI 40790
  1. Dose form (SCDF) Delayed Release Oral Tablet RxCUI 373222
    In current FDA listings
    Its 2 strengths (SCD)
  2. Dose form (SCDF) Injection RxCUI 1737587
    In current FDA listings
    Its 4 strengths (SCD)
  3. Dose form (SCDF) Oral Granules RxCUI 763305
    In current FDA listings
    Its strength (SCD)

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Pantoprazole Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Pantoprazole: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick a form, the generic or the brand, and a strength to see how its price has changed since Nov 2023.

Form
Strength

For the generic 40 mg injection, pharmacies paid an average of $2.37 each as of Nov 18, 2026, up 28% from $1.85 a year earlier.

What pharmacies pay now
$2.37
each, as of Nov 18, 2026
Last 4 weeks
No change
from $2.37 on Oct 21, 2026
Last 12 months
Up 28%
from $1.85 on Nov 19, 2025
Lowest and highest since Apr 2024
$1.85 to $3.00
each

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Generic 40 mg injection: the average pharmacy price each, the last survey of each month
MonthPharmacy price
Nov 2026$2.37
Oct 2026$2.37
Sep 2026$2.37
Aug 2026$2.37
Jul 2026$2.37
Jun 2026$2.37
May 2026$2.37
Apr 2026$2.37
Mar 2026$2.37
Feb 2026$2.37
Jan 2026$2.37
Dec 2025$1.85
Nov 2025$1.85
Oct 2025$1.85
Sep 2025$1.85
Aug 2025$1.85
Jul 2025$1.85
Jun 2025$1.85
May 2025$1.85
Apr 2025$1.95
Mar 2025$1.99
Feb 2025$2.06
Jan 2025$2.19
Dec 2024$2.34
Nov 2024$2.43
Oct 2024$2.53
Sep 2024$2.53
Aug 2024$2.62
Jul 2024$2.97
Jun 2024$3.00
May 2024$2.85
Apr 2024$2.72
See all 10 prices in a table
FormStrengthVersion What pharmacies pay
Injection · Intravenous 40 mg Generic $2.37 each NDC details & price history
Injection · Intravenous 40 mg/10 mL Generic $2.37 each NDC details & price history
Delayed-release tablet · Oral 20 mg Generic $0.043 per tablet NDC details & price history
Delayed-release tablet · Oral 20 mg Protonix (brand) $14.31 per tablet NDC details & price history
Delayed-release tablet · Oral 40 mg Generic $0.038 per tablet NDC details & price history
Delayed-release tablet · Oral 40 mg Protonix (brand) $14.20 per tablet NDC details & price history
Oral powder · Oral 40 mg Generic $2.85 each NDC details & price history
Oral powder · Oral 40 mg Protonix (brand) $14.08 each NDC details & price history
Oral powder · Oral 40 mg Generic $2.85 each NDC details & price history
Delayed-release tablet · Oral 40 mg Generic $0.038 per tablet NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Pantoprazole Brand Names

Pantoprazole has 3 brand names on record: Protonix, Protonix I.V. and Protonix Delayed-Release. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Protonix the first brand, 2000 Protonix I.V. Protonix Delayed-Release

Who Makes Pantoprazole: Manufacturers and Labelers

68 companies list Pantoprazole products with the FDA. By number of product records, the largest are Cardinal Health 107, LLC, NuCare Pharmaceuticals,Inc., Bryant Ranch Prepack. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Cardinal Health 107, LLC 10 NuCare Pharmaceuticals,Inc. 10 Bryant Ranch Prepack 7 A-S Medication Solutions 6 Asclemed USA, Inc. 6 NorthStar RxLLC 5 Proficient Rx LP 5 Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. 5 Advanced Rx Pharmacy of Tennessee, LLC 4 Camber Pharmaceuticals, Inc. 4 Hawaii Repack, Inc. 4 Advanced Rx of Tennessee, LLC 3 American Health Packaging 3 Aphena Pharma Solutions - Tennessee, LLC 3 Aurobindo Pharma Limited 3 AvPAK 3 Baxter Healthcare Corporation 3 Coupler LLC 3 Major Pharmaceuticals 3 Northwind Health Company, LLC 3 QPharma Inc 3 Remedyrepack Inc. 3 Amneal Pharmaceuticals LLC 2 Chartwell RX, LLC 2

…and 44 more on the FDA NDC directory.

Sources for This Pantoprazole Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated May 18, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Pantoprazole.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 124 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
124
Finished products in the current FDA directory
168
Companies listing them (makers, repackagers, distributors)
68
FDA labeler codes behind them ⓘ
70
Linked representative label ⓘ
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Linked label effective
May 18, 2026
Composite sections available
24
Linked SPL Set ID
08098cb2-c048-4640-f387-6beec4a38936
Linked SPL Document ID
b1adaee5-9353-48ce-bde4-f169a3787e30
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →